tirzepatide still available is compound Tirzepatide — Compounded dual GIP/GLP-1 medication Tirzepatide: Injection Home Kit –

105 TuckerJ

Stopping treatment suddenly can lead to weight regain GLP-1 medicines help manage appetite, so stopping them quickly can bring back old eating patterns

In further support of this ex vivo finding, the GIPR monoagonist LY3537021 reduced body weight by ~4.1% over 8 weeks in patients with T2D (n = 18) (57)

Oral GLP-1 therapies activate GLP-1 receptors to boost insulin secretion, slow gastric emptying, and reduce appetite, leading to weight loss and improved glucose control

Patient-reported outcomes in weight loss trials include spontaneous mentions of reduced worry, better sleep quality, and decreased panic-like episodes

Researchers concluded this could be because females have a lower average body weight compared to males, which allowed for more exposure to the drug